Sociedad Americana de Hirudoterapia

Mutational analysis of antistasin, an inhibitor of blood coagulation factor Xa derived from the Mexican leech Haementeria officinalis

Research article published in Thrombosis research (1994)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Desarrollo de fármacosTheunissen HJ et al. · Thrombosis research, 1994

Abstract

Antistasin is a Factor Xa inhibitor that is present in the salivary glands of the Mexican leech Haementeria officinalis. The antistasin protein consists of 119 amino acids, of which residues 1-55 (domain I) are 56% similar to residues 56-110 (domain II). Of the nine C-terminal amino acids (residues 111-119; domain III), four are positively charged. The reactive site for Factor Xa is located in domain I. In this study we assessed the role of separate domains and of individual amino acids in the reactive site for the inhibition of Factor Xa. A series of mutants was constructed and expressed in Chinese hamster ovary (CHO) cells. In vitro chromogenic assays for Factor Xa show that domain I is sufficient for inhibition of Factor Xa. Domains II and III neither contain any intrinsic Factor Xa inhibitory activity, nor contribute to the activity of domain I. Furthermore, domain II does not become a Factor Xa inhibitor by partially adaptating its sequence towards that of the reactive site in domain I. Mutation of the cysteine at position 33 is not crucial for Factor Xa inhibition, suggesting a relatively rigid reactive site loop structure.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAmino Acid SequenceAnimalsAnticoagulantsCHO CellsCricetinaeDNA Mutational AnalysisDNA ProbesFactor Xa InhibitorsInvertebrate HormonesLeechesMolecular Sequence Data

Resumen

Mutational analysis of antistasin, an inhibitor of blood coagulation factor Xa derived from the Mexican leech Haementeria officinalis.

Por qué esto importa para la hirudoterapia

This study performed mutational analysis of antistasin, a factor Xa inhibitor from the salivary glands of the Mexican leech Haementeria officinalis, by expressing domain and point mutants in CHO cells. In vitro chromogenic assays showed that domain I (residues 1–55) alone is sufficient for factor Xa inhibition, while domains II and III contribute no intrinsic activity, and mutation of cysteine-33 is not crucial, suggesting a relatively rigid reactive-site loop. This is relevant to ASH as a structure-function study of a leech-secretome anticoagulant. Caveat: the work is entirely in vitro using recombinant protein in cell culture, with no animal or clinical data.

Citación

Mutational analysis of antistasin, an inhibitor of blood coagulation factor Xa derived from the Mexican leech Haementeria officinalis

Theunissen HJ et al. · Thrombosis research, 1994

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.